Human-grade purified collagenase for the treatment of experimental arterial chronic total occlusion
Authors:
- Nafiseh NiliNNNafiseh Nili
- Beiping QiangBQBeiping Qiang
- Thierry CharronTCThierry Charron
- Jagdish ButanyJBJagdish Butany
- Bradley H. StraussBSBradley H. Strauss
- 1 April 2005
- journal article
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 6 (2) , 65-69
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Collagenase Plaque Digestion for Facilitating Guide Wire Crossing in Chronic Total OcclusionsCirculation, 2003
- Arterial repair after stenting and the effects of gm6001, a matrix metalloproteinase inhibitorJACC, 2002
- Non-surgical treatment of patients with peripheral vascular diseaseBritish Medical Bulletin, 2001
- Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experienceJACC, 2001
- Improvement in left ventricular ejection fraction and wall motion after successful recanalization of chronic coronary occlusionsEuropean Heart Journal, 1998
- Coronary Recanalization by Elective Angioplasty Prevents Ventricular Dilation After Anterior Myocardial InfarctionJACC, 1996
- Cloning and nucleotide sequence analysis of the colH gene from Clostridium histolyticum encoding a collagenase and a gelatinaseJournal of Bacteriology, 1994
- Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization.Circulation, 1993
- Results of coronary angioplasty of chronic total occlusions (the National Heart, Lung, and Blood Institute 1985–1986 Percutaneous Transluminal Angioplasty Registry)The American Journal of Cardiology, 1992
- Use of percutaneous transluminal coronary angioplasty: Results of a current surveyThe American Journal of Cardiology, 1988